117 related articles for article (PubMed ID: 24968791)
21. Ezrin expression in tissue microarray of primary and recurrent gliomas.
Tynninen O; Carpén O; Jääskeläinen J; Paavonen T; Paetau A
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):472-7. PubMed ID: 15488023
[TBL] [Abstract][Full Text] [Related]
22. [Changes of folate receptor -α protein expression in human gliomas and its clinical relevance].
Wu H; Zhan Y; Qu Y; Qi X; Li J; Yu C
Zhonghua Wai Ke Za Zhi; 2014 Mar; 52(3):202-7. PubMed ID: 24785460
[TBL] [Abstract][Full Text] [Related]
23. Fibroblast growth factor receptor-2 expression in thyroid tumor progression: potential diagnostic application.
Redler A; Di Rocco G; Giannotti D; Frezzotti F; Bernieri MG; Ceccarelli S; D'Amici S; Vescarelli E; Mitterhofer AP; Angeloni A; Marchese C
PLoS One; 2013; 8(8):e72224. PubMed ID: 23977259
[TBL] [Abstract][Full Text] [Related]
24. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].
Chen H; Huang Q; Zhai DZ; Dong J; Wang AD; Lan Q
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):484-8. PubMed ID: 18069625
[TBL] [Abstract][Full Text] [Related]
25. [Correlation of hTERT expression to maspin and bFGF expression and their significance in glioma].
Wang DL; Wang YF; Shi GS; Huang H
Ai Zheng; 2007 Jun; 26(6):601-6. PubMed ID: 17562265
[TBL] [Abstract][Full Text] [Related]
26. Expression level of ECT2 proto-oncogene correlates with prognosis in glioma patients.
Sano M; Genkai N; Yajima N; Tsuchiya N; Homma J; Tanaka R; Miki T; Yamanaka R
Oncol Rep; 2006 Nov; 16(5):1093-8. PubMed ID: 17016598
[TBL] [Abstract][Full Text] [Related]
27. Concomitant microRNA-31 downregulation and radixin upregulation predicts advanced tumor progression and unfavorable prognosis in patients with gliomas.
Wang S; Jiao B; Geng S; Song J; Liang Z; Lu S
J Neurol Sci; 2014 Mar; 338(1-2):71-6. PubMed ID: 24380686
[TBL] [Abstract][Full Text] [Related]
28. Deregulated expression of the clock genes in gliomas.
Chen Z; Liu P; Li C; Luo Y; Chen I; Liang W; Chen X; Feng Y; Xia H; Wang F
Technol Cancer Res Treat; 2013 Feb; 12(1):91-7. PubMed ID: 22905804
[TBL] [Abstract][Full Text] [Related]
29. Decreased FOXD3 Expression Is Associated with Poor Prognosis in Patients with High-Grade Gliomas.
Du W; Pang C; Wang D; Zhang Q; Xue Y; Jiao H; Zhan L; Ma Q; Wei X
PLoS One; 2015; 10(5):e0127976. PubMed ID: 26011451
[TBL] [Abstract][Full Text] [Related]
30. Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas.
Andersson U; Guo D; Malmer B; Bergenheim AT; Brännström T; Hedman H; Henriksson R
Acta Neuropathol; 2004 Aug; 108(2):135-42. PubMed ID: 15148612
[TBL] [Abstract][Full Text] [Related]
31. FGFR2 isoforms support epithelial-stromal interactions in thyroid cancer progression.
Guo M; Liu W; Serra S; Asa SL; Ezzat S
Cancer Res; 2012 Apr; 72(8):2017-27. PubMed ID: 22345151
[TBL] [Abstract][Full Text] [Related]
32. Stratifin expression is a novel prognostic factor in human gliomas.
Deng J; Gao G; Wang L; Wang T; Yu J; Zhao Z
Pathol Res Pract; 2011 Nov; 207(11):674-9. PubMed ID: 21940111
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathologic significance of cystatin C expression in gliomas.
Nakabayashi H; Hara M; Shimuzu K
Hum Pathol; 2005 Sep; 36(9):1008-15. PubMed ID: 16153465
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of pituitary tumor-transforming gene (PTTG)-1 is correlated with poor prognosis in glioma patients.
Genkai N; Homma J; Sano M; Tanaka R; Yamanaka R
Oncol Rep; 2006 Jun; 15(6):1569-74. PubMed ID: 16685397
[TBL] [Abstract][Full Text] [Related]
35. Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma.
Hau P; Ruemmele P; Kunz-Schughart LA; Doerfelt A; Hirschmann B; Lohmeier A; Koch H; Mueller A; Bogdahn U; Bosserhoff AK
Oncol Rep; 2004 Dec; 12(6):1355-64. PubMed ID: 15547763
[TBL] [Abstract][Full Text] [Related]
36. Correlation of apparent diffusion coefficient with Ki-67 in the diagnosis of gliomas.
Yin Y; Tong D; Liu XY; Yuan TT; Yan YZ; Ma Y; Zhao R
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Oct; 34(5):503-8. PubMed ID: 23134828
[TBL] [Abstract][Full Text] [Related]
37. Homeobox‑containing protein 1 loss is associated with clinicopathological performance in glioma.
Zhang P; Liu Q; Yan S; Yuan G; Shen J; Li G
Mol Med Rep; 2017 Oct; 16(4):4101-4106. PubMed ID: 28731165
[TBL] [Abstract][Full Text] [Related]
38. Fibroblast growth factor receptor expression reflects cellular differentiation in human oral squamous carcinoma cell lines.
Drugan CS; Paterson IC; Prime SS
Carcinogenesis; 1998 Jun; 19(6):1153-6. PubMed ID: 9667757
[TBL] [Abstract][Full Text] [Related]
39. [Nuclear expression of Survivin in glioma and its correlation to prognosis].
Pan Y; Hu WH; Xie D; Wu HX; Xiang J; Liu YD; Wu QL; Liu YH
Ai Zheng; 2006 May; 25(5):635-9. PubMed ID: 16687089
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of IGFBP5, but not IGFBP3, correlates with the histologic grade of human diffuse glioma: a tissue microarray and immunohistochemical study.
Wang H; Wang H; Zhang W; Fuller GN
Technol Cancer Res Treat; 2006 Jun; 5(3):195-9. PubMed ID: 16700616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
